WCN25-3902 LONG TERM RENAL OUTCOMES OF PATIENTS WITH MEMBRANOUS LUPUS NEPHRITIS ATTENDING A TERTIARY CARE CENTER OF NORTH INDIA
Membranous lupus nephritis (MLN) comprises nearly 10-20% of total cases of lupus nephritis and is often associated with nephrotic syndrome. Steroids with Mycophenolate Mofetil (MMF) or Cyclophosphamide (CYC) are the two most common treatments, however, their long-term outcomes have not been studied extensively. This study outlines the long-term outcomes of MLN patients being treated at a tertiary care centre of North India.
Authors
- Narayan Prasad (ORCID: https://orcid.org/0000-0001-9801-0474)
- Jeyakumar Meyyappan (ORCID: https://orcid.org/0000-0002-4625-1169)
- Vamsidhar Veeranki (ORCID: https://orcid.org/0000-0002-7446-281X)
- Yashendu Sarda
- Ravi Shankar Kushwaha
Institutions
- Centre of Biomedical Research (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.435
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00